← back to search

Xiaojia Huang

Fujian Medical University · CN
Area of research
Cancer Research · Oncology
Research interest
Research interests include MicroRNA in disease regulation, Breast Cancer Treatment Studies, Cancer Cells and Metastasis, and Cancer-related molecular mechanisms research.
h-index
21
citations
1,793
works
41
NIH funding
primary concept
email

Recent publications

Transcriptome analysis reveals therapeutic potential of NAMPT in protecting against abdominal aortic aneurysm in human and mouse
Bioactive Materials 2023cited by 17position: middledoi
Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma
Signal Transduction and Targeted Therapy 2020cited by 67position: middledoi
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer
Molecular Cancer 2019cited by 225position: middledoi
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
Theranostics 2018cited by 303position: middledoi
SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
Frontiers in Pharmacology 2018cited by 75position: middledoi
Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a
Oncogene 2018cited by 70position: firstdoi
PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
Journal of Experimental & Clinical Cancer Research 2017cited by 88position: firstdoi
Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients
The Breast 2017cited by 36position: middledoi
The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer
Scientific Reports 2016cited by 134position: middledoi
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
Oncotarget 2016cited by 72position: middledoi
The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment
The Breast 2015cited by 69position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hailin Tang · Sun Yat-sen University8 papers (2016–2019)Xiaoming Xie · Nanchang University6 papers (2015–2018)Lu Yang · Hainan Medical University4 papers (2017–2019)Cailu Song · Sun Yat-sen University4 papers (2016–2018)Jiahuai Wen · Guangzhou University of Chinese Medicine3 papers (2015–2017)Xinhua Xie · Sun Yat-sen University3 papers (2016–2018)Peng Liu · Sun Yat-sen University3 papers (2016–2018)Feng Ye · Sichuan University3 papers (2016–2017)Yanning Yang · Yan'an University2 papers (2015–2017)Yanan Kong · Sun Yat-sen University2 papers (2018–2019)Jin Wang · North China Electric Power University2 papers (2018–2019)Bo Chen · Shihezi University2 papers (2016–2018)Weidong Wei · Shaoxing City Women and Children Hospital2 papers (2016–2018)Xiangsheng Xiao · Sun Yat-sen University2 papers (2016–2017)Jun Wu · Nanjing Agricultural University1 papers (2020–2020)Shuaijie Li · Qingdao University1 papers (2016–2016)Xiaofang Guo · Sun Yat-sen University Cancer Center1 papers (2017–2017)Xiaohui Deng · Shanghai Jiao Tong University1 papers (2023–2023)Danian Dai · Guangdong Academy of Medical Sciences1 papers (2018–2018)Changye Zou · Sun Yat-sen University1 papers (2020–2020)